Montelukast protects against renal ischemia/reperfusion injury in rats

Pharmacological Research

Volumn 54, Issue 1, 2006, Pages 65-71

  Şener, Göksel ^a   Şehirli, Özer ^a   Velioǧlu Öǧünç, Ayliz ^a   Çetinel, Şule ^a   Gedik, Nursal ^a   Caner, Metin ^b   Sakarcan, Abdullah ^c   Yeǧen, Berrak Ç ^a  

^a MARMARA UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokines; Ischemia reperfusion; Kidney; Leukotrienes; Montelukast; Myeloperoxidase

Indexed keywords

ANTIOXIDANT; CREATININE; GLUTATHIONE; INTERLEUKIN 6; LACTATE DEHYDROGENASE; LEUKOTRIENE B4; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LIPID; LUCIGENIN; LUMINOL; MALONALDEHYDE; MONTELUKAST; MYELOPEROXIDASE; PEPTIDOLEUKOTRIENE; REACTIVE OXYGEN METABOLITE; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; DECAPITATION; DRUG EFFECT; ENZYME ACTIVITY; HISTOLOGY; KIDNEY ISCHEMIA; KIDNEY PARENCHYMA; KIDNEY PERFUSION; LIPID PEROXIDATION; MALE; NEPHRECTOMY; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; REPERFUSION INJURY; UREA NITROGEN BLOOD LEVEL;

ACETATES; ANIMALS; BLOOD UREA NITROGEN; CREATININE; GLUTATHIONE; INTERLEUKIN-1; INTERLEUKIN-6; KIDNEY; L-LACTATE DEHYDROGENASE; LEUKOTRIENE ANTAGONISTS; LEUKOTRIENE B4; MALE; MALONDIALDEHYDE; NEUTROPHIL INFILTRATION; PEROXIDASE; QUINOLINES; RATS; RATS, WISTAR; REPERFUSION INJURY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33744921091     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2006.02.007     Document Type: Article

References (50)

1. Takada M., Nadeau K.C., Shaw G.D., Marquette K.A., and Tilney N.L. Prevention of late renal changes after initial ischemia/reperfusion injury by blocking early selectin binding. Transplantation 64 (1997) 1520-1525
2. Matin S.F., and Novick A.C. Renal dysfunction associated with staged bilateral partial nephrectomy. The importance of operative positioning. J Urol 165 (2001) 880-881
3. Rispoli P., Conforti M., Melloni C., Barile G., and Raso A.M. Superior mesenteric and renal artery embolism during PTA and re-stenting of infrarenal abdominl aorta. Report of a case and review of the literature. J Cardiovasc Surg 41 (2000) 763-766
4. Mangano C.M., Diamondstone L.S., Ramsay J.G., Aggarwal A., Herskowitz A., and Mangano D.T. Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study Peri-operative Ischemia Research Group. Ann Int Med 128 (1998) 194-203
5. Kazmers A., Jacobs L., and Perkins A. The impact of complications after vascular surgery in Veterans Affairs Medical Centers. J Surg Res 67 (1997) 62-66
6. Ichimura T., Bonventre J.V., Bailly V., Wei H., Hession C.A., Cate R.L., et al. Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J Biol Chem 273 (1998) 4135-4142
7. Krysztopik R.J., Bentley F.R., Spain D.A., Wilson M.A., and Garrison R.N. Free radical scavenging by lazaroids improves renal blood flow during sepsis. Surgery 120 (1996) 657-662
8. Ricardo S.D., and Diamond J.R. The role of macrophages and reactive oxygen species in experimental hydronephrosis. Semin Nephrol 18 (1998) 612-621
9. Donnahoo K.K., Meng X., Ayala A., Cain M.P., Harken A.H., and Meldrum D.R. Early kidney TNF-α expression mediates neutrophil infiltration and injury after renal ischemia-reperfusion. Am J Physiol 277 (1999) R922-R929
10. Koo D.D., Welsh K.I., West N.E., Channon K.M., Penington A.J., Roake J.A., et al. Endothelial cell protection against ischemia/reperfusion injury by lecithinized superoxide dismutase. Kidney Int 60 (2001) 786-796
11. Rabb H., O'Meara Y.M., Maderna P., Coleman P., and Brady H.R. Leukocytes, cell adhesion molecules and ischemic acute renal failure. Kidney Int 51 (1997) 1463-1468
12. Ishikawa F., and Miyazaki S. New biodefense strategies by neutrophils. Arch Immunol Ther Exp (Warsz) 53 (2005) 226-233
13. Kelly K.J., Williams W.W., Colvin R.B., Meehan S.M., Springer A.T., Ramos J.G., et al. Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury. J Clin Invest 97 (1996) 1056-1063
14. Willerson J.T. Pharmacological approaches to reperfusion injury. Adv Pharmacol 39 (1997) 291-312
15. Souza D.G., Coutinho S.F., Silveria M.R., Cara D.C., and Teixeria M.M. Effects of a BT receptor antagonist on local and remote reperfusion injuries after transient ischemia of the superior mesenteric artery in rats. Eur J Pharmacol 403 (2000) 121-128
16. Souza D.G., Cara D.C., Cassali D.G., Coutinho S.F., Silveria M.R., Andrade S.P., et al. Effects of the PAF receptor antagonist UK74505 on local and remote reperfusion injuries following ischemia mesenteric artery in the rat. Br J Pharmacol 131 (2000) 1800-1808
17. Damtew B., Marino J.A., Fratianne R.B., and Spagnuolo P.J. Neutrophil lipoxygenase metabolism and adhesive function following acute thermal injury. J Lab Clin Med 121 (1993) 328-336
18. Wallace J.L., Beck P.L., and Morris G.P. Is there a role for leukotrienes as mediators of ethanol-induced gastric mucosal damage?. Am J Physiol 254 1 Pt 1 (1988) G117-G123
19. Carsin H., Bargues L., Stephanazzi J., Paris A., Aubert P., and Le Bever H. Inflammatory reaction and infection in severe burns. Pathol Biol (Paris) 50 (2002) 93-101
20. Wallace J.L., McKnight G.W., Keenan C.M., Byles N.I., and MacNaughton W.K. Effects of leukotrienes on susceptibility of the rat stomach to damage and investigation of the mechanism of action. Gastroenterology 98 5 Pt 1 (1990) 1178-1186
21. Konturek S.J., Brozozowski T., Drozdowicz D., and Beck G. Role of leukotrienes in acute gastric lesions induced by ethanol, taurocholate, aspirin, platelet-activating factor and stress in rats. Dig Dis Sci 33 (1988) 806-813
22. Şener G., Kabasakal L., Çetinel S., Contuk G., Gedik N., and Yegen B. Leukotriene receptor blocker montelukast protects against burn-induced oxidative injury of the skin and remote organs. Burns 31 (2005) 587-596
23. Şener G., Şehirli O., Çetinel S., Ercan F., Yüksel M., Gedik N., et al. Amelioration of sepsis-induced hepatic and ileal injury in rats by the leukotriene receptor blocker montelukast. Prostoglandins Leukot Essent Fatty Acids 73 6 (2005) 453-462
24. Slot C. Plasma creatinine determination. A new and specific Jaffe reaction method. Scand J Clin Lab Invest 17 (1965) 381-387
25. Talke H., and Schubert G.E. Enzymatic urea determination in the blood and serum in the Warburg optical test. Klinische Wochenschrift 43 (1965) 174-175
26. Martinek R.G. A rapid ultraviolent spectrophotomeetric lactic dehydrogenase assay. Clin Chem Acta 40 (1972) 91-99
27. Ohara Y., Peterson T.E., and Harrisorn D.G. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 92 (1993) 2546-2551
28. Davies G.R., Simmonds N.J., Stevens T.R., Sheaff M.T., Banatvala N., Laurenson I.F., et al. Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo. Gut 35 (1994) 179-185
29. Beuge J.A., and Aust S.D. Microsomal lipid peroxidation. Meth Enzymol 52 (1978) 302-311
30. Beutler E. Glutathione in red blood cell metabolism. A manual of biochemical methods (1975), Grune & Stratton, New York pp. 112-4
31. Bradley P.P., Priebat D.A., Christersen R.D., and Rothstein G. Measurement of cutaneous inflammation. Estimation of neutrophil content with an enzyme marker. J Invest Dermatol 78 (1982) 206-209
32. Hillegass L.M., Griswold D.E., Brickson B., and Albrightson-Winslow C. Assessment of myeloperoxidase activity in whole rat kidney. J Pharmacol Meth 24 (1990) 285-295
33. Williams P.H., Lopez D.B., Chan C., Ezrin A., and Hottendorf R. Characterization of renal ischemia-reperfusion injury in rats. J Pharmacol Toxicol Meth 37 (1997) 1-7
34. Granger D.N., and Korthuis R.J. Physiological mechanisms of postischemic tissue injury. Ann Rev Physiol 57 (1995) 311-332
35. Singh D., Chander V., and Chopra K. Carvedilol attenuates ischemia-reperfusion-induced oxidative renal injury in rats. Fundam Clin Pharmacol 18 (2004) 627-634
36. Singh D., and Chopra K. Effect of trimetazidine on renal ischemia/reperfusion injury in rats. Pharmacol Res 50 (2004) 623-629
37. Eschwege P., Paradis V., Conti M., Holstege A., Richet F., Devete J., et al. In situ detection of lipid peroxidation by-products as markers of renal ischemia injuries in rat kidneys. J Urol 162 (1999) 553-557
38. Heinzelmann M., Mercer-Jones M.A., and Passmore J.C. Neutrophils and renal failure. Am J Kidney Dis 34 (1999) 384-399
39. Takamatsu Y., Shimada K., Chijiiwa K., Kuroki S., Yamaguchi K., and Tanaka M. Role of leukotrienes on hepatic ischemia/reperfusion injury in rats. J Surg Res 119 (2004) 14-20
40. Baba T., Black K.L., Ikezaki K., Chen K.N., and Becker D.P. Intracarotid infusion of leukotriene C4 selectively increases blood-brain barrier permeability after focal ischemia in rats. J Cereb Blood Flow Metab 11 (1991) 638-643
41. Yu G.L., Wei E.Q., Zhang S.H., Xu H.M., Chu L.S., Zhang W.P., et al. Montelukast, a cysteinyl leukotriene receptor-1 antagonist, dose- and time-dependently protects against focal ischemia in mice. Pharmacology 73 (2005) 31-40
42. Zhang S.H., Wei E.Q., Zhu C.Y., Chen Z., and Zhang S.F. Protective effect of ONO-1078, a leukotriene receptor antagonist, on focal cerebral ischemia induced by endothelin-1 in rats. Acta Pharm Sin 39 (2004) 1-4
43. Patel N.S., Cuzzocrea S., Chatterjee P.K., Di Paola R., Sautebin L., Britti D., et al. Reduction of renal ischemia-reperfusion injury in 5-lipoxygenase knockout mice and by the 5-lipoxygenase inhibitor zileuton. Mol Pharmacol 66 (2004) 220-227
44. Matsui N., Fukuishi N., Fukuyama Y., Yasui Y., and Akagi M. Protective effect of the 5-lipoxygenase inhibitor ardisiaquinone on hepatic ischemia-reperfusion injury in rats. Planta Med 71 (2005) 717-720
45. Souza D.G., Pinho V., Cassali G.D., Poole S., and Teixeria M.M. Effect of a BLT receptor antagonist in a model of severe ischemia and reperfusion injury in the rat. Eur J Pharmacol 440 (2002) 61-69
46. Noiri E., Yokomizo T., Nakao A., Izumi T., Fujita T., Kimura S., et al. An in vivo approach showing the chemotactic activity of leukotriene B4 in acute renal ischemic-reperfusion injury. Proc Natl Acad Sci 97 (2000) 823-828
47. Katoh T., Lianos E.A., Fukunaga M., Takahashi K., and Badr K.F. Leukotriene D4 is a mediator of proteinuria and glomerular hemodynamic abnormalities in passive Heymann nephritis. J Clin Invest 91 (1993) 1507-1515
48. Pompermayer K., Souza D.G., Lara G.G., Silveira K.D., Cassali G.D., Andrade A.A., et al. The ATP-sensitive potassium channel blocker glibenclamide prevents renal ischemia/reperfusion injury in rats. Kidney Int 67 (2005) 1785-1796
49. Teng S., Kurata S., Katoh I., Georgieva G.S., Nosaka T., Mitaka C., et al. Cytokine mRNA expression in unilateral ischemic-reperfused rat lung with salt solution supplemented with low-endotoxin or standard bovine serum albumin. Am J Physiol Lung Cell Mol Physiol 286 1 (2004) L137-L142
50. Kher A., Meldrum K.K., Hile K.L., Wang M., Tsai B.M., Turrentine M.W., et al. Aprotinin improves kidney function and decreases tubular cell apoptosis and proapoptotic signaling after renal ischemia-reperfusion. J Thorac Cardiovasc Surg 130 (2005) 662-669